Abstract
During the past decades, extracellular vesicles (EVs) have emerged as an attractive drug delivery system. Here, we assess their pre-clinical applications, in the form of a systematic review. For each study published in the past decade, disease models, animal species, EV donor cell types, active pharmaceutical ingredients (APIs), EV surface modifications, API loading methods, EV size and charge, estimation of EV purity, presence of biodistribution studies and administration routes were quantitatively analyzed in a defined and reproducible way. We have interpreted the trends we observe over the past decade, to define the niches where to apply EVs for drug delivery in the future and to provide a basis for regulatory guidelines.
| Original language | English |
|---|---|
| Article number | 113801 |
| Pages (from-to) | 1-39 |
| Journal | Advanced Drug Delivery Reviews |
| Volume | 175 |
| DOIs | |
| Publication status | Published - Aug 2021 |
Bibliographical note
Copyright © 2021 Elsevier B.V. All rights reserved.Keywords
- Liposomes
- Systematic review
- Drug Delivery
- Extracellular Vesicles
- Preclinical animal models
- Clinical trial
Fingerprint
Dive into the research topics of 'Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver